CD8A and neoplasm: Consistent with previous studies, the proportion of CD8+ tumor-infiltrating lymphocytes exhibited notable increases in response to exposure of Gem- and HA/ZIF-8@Gem/D-1-MT NPs-treated MDSCs when compared to the ones without Gem (Fig. 5O-R).